• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药用植物作为发现针对癌症耐药性治疗新结构的潜在资源。

Medicinal plants as a potential resource for the discovery of novel structures towards cancer drug resistance treatment.

作者信息

Nguyen Minh Hien, Nguyen Thi Yen Nhi, Le Thien Han Nguyen, Le Thi Ngoc Tam, Chau Ngoc Trong Nghia, Le Tu Manh Huy, Huy Nguyen Bui Quoc

机构信息

University of Health Sciences, Vietnam National University Ho Chi Minh City, YA1 Administrative Building, Hai Thuong Lan Ong Street, Dong Hoa Ward, Di An City, Binh Duong Province, Viet Nam.

Vietnam National University Ho Chi Minh City, Linh Trung Ward, Thu Duc City, Ho Chi Minh city, Viet Nam.

出版信息

Heliyon. 2024 Oct 11;10(20):e39229. doi: 10.1016/j.heliyon.2024.e39229. eCollection 2024 Oct 30.

DOI:10.1016/j.heliyon.2024.e39229
PMID:39492898
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11530815/
Abstract

Despite extensive research in chemotherapy, global cancer concerns persist, exacerbated by the challenge of drug resistance, which imposes economic and medical burdens. Natural compounds, particularly secondary metabolites from medicinal plants, present promising avenues for overcoming cancer drug resistance due to their diverse structures and essential pharmacological effects. This review provides a comprehensive exploration of cancer cell resistance mechanisms and target actions for reversing resistance and highlights the and efficacy of noteworthy alkaloids, flavonoids, and other compounds, emphasizing their potential as therapeutic agents. The molecular properties supporting ligand interactions are thoroughly examined, providing a robust theoretical foundation. The review concludes by discussing methods including quantitative structure-activity relationships and molecular docking, offering insights into screening potential candidates. Current trends in clinical treatment, contributing to a holistic understanding of the multifaceted approaches to address cancer drug resistance are also outlined.

摘要

尽管在化疗方面进行了广泛研究,但全球癌症问题依然存在,耐药性这一挑战加剧了这些问题,给经济和医疗带来了负担。天然化合物,特别是药用植物的次生代谢产物,由于其多样的结构和重要的药理作用,为克服癌症耐药性提供了有前景的途径。本综述全面探讨了癌细胞耐药机制以及逆转耐药性的靶向作用,并强调了值得关注的生物碱、黄酮类化合物和其他化合物的疗效,突出了它们作为治疗剂的潜力。对支持配体相互作用的分子特性进行了深入研究,提供了坚实的理论基础。综述最后讨论了包括定量构效关系和分子对接在内的方法,为筛选潜在候选物提供了见解。还概述了临床治疗的当前趋势,有助于全面理解应对癌症耐药性的多方面方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/627c/11530815/95f1e0df61df/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/627c/11530815/55a26dd0aea3/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/627c/11530815/7b7d15227d34/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/627c/11530815/9ad34c152c1c/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/627c/11530815/e06d2d1088c0/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/627c/11530815/95f1e0df61df/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/627c/11530815/55a26dd0aea3/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/627c/11530815/7b7d15227d34/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/627c/11530815/9ad34c152c1c/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/627c/11530815/e06d2d1088c0/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/627c/11530815/95f1e0df61df/gr5.jpg

相似文献

1
Medicinal plants as a potential resource for the discovery of novel structures towards cancer drug resistance treatment.药用植物作为发现针对癌症耐药性治疗新结构的潜在资源。
Heliyon. 2024 Oct 11;10(20):e39229. doi: 10.1016/j.heliyon.2024.e39229. eCollection 2024 Oct 30.
2
Exploration of medicinal plants as potential therapeutics against COVID-19: molecular insights and drug development prospects with other significant medicinal information a retrospective exposition.探索药用植物作为抗COVID-19的潜在疗法:分子见解、药物开发前景及其他重要药用信息——回顾性阐述
J Pharm Pharmacol. 2025 Jan 6;77(1):18-31. doi: 10.1093/jpp/rgae074.
3
Herbal Therapies for Cancer Treatment: A Review of Phytotherapeutic Efficacy.用于癌症治疗的草药疗法:植物治疗功效综述
Biologics. 2024 Sep 10;18:229-255. doi: 10.2147/BTT.S484068. eCollection 2024.
4
A Medicinal Chemist's Perspective Towards Structure Activity Relationship of Heterocycle Based Anticancer Agents.基于杂环的抗癌剂的结构活性关系的药用化学家视角。
Curr Top Med Chem. 2022;22(6):493-528. doi: 10.2174/1568026622666220111142617.
5
Medicinal plants used against hepatic disorders in Bangladesh: A comprehensive review.用于治疗孟加拉国肝脏疾病的药用植物:全面综述。
J Ethnopharmacol. 2022 Jan 10;282:114588. doi: 10.1016/j.jep.2021.114588. Epub 2021 Sep 1.
6
Antimicrobial Metabolites of Caucasian Medicinal Plants as Alternatives to Antibiotics.高加索药用植物的抗菌代谢产物作为抗生素的替代品
Antibiotics (Basel). 2024 May 24;13(6):487. doi: 10.3390/antibiotics13060487.
7
Antioxidative and therapeutic potential of selected Australian plants: A review.抗氧化和治疗潜力的选定的澳大利亚植物: 一个审查。
J Ethnopharmacol. 2021 Mar 25;268:113580. doi: 10.1016/j.jep.2020.113580. Epub 2020 Nov 13.
8
Therapeutic value of steroidal alkaloids in cancer: Current trends and future perspectives.甾体生物碱在癌症治疗中的价值:当前趋势和未来展望。
Int J Cancer. 2019 Oct 1;145(7):1731-1744. doi: 10.1002/ijc.31965. Epub 2019 Jan 21.
9
Cytotoxic activity of medicinal plants of the Kakamega County (Kenya) against drug-sensitive and multidrug-resistant cancer cells.卡卡梅加县(肯尼亚)药用植物对敏感和多药耐药癌细胞的细胞毒性活性。
J Ethnopharmacol. 2018 Apr 6;215:233-240. doi: 10.1016/j.jep.2018.01.004. Epub 2018 Jan 5.
10
Computer-Aided Drug Design Applied to Secondary Metabolites as Anticancer Agents.计算机辅助药物设计在抗癌次生代谢产物中的应用。
Curr Top Med Chem. 2020;20(19):1677-1703. doi: 10.2174/1568026620666200607191838.

引用本文的文献

1
Synthesis of AgO/Ag Nanoparticles Using Puerarin: Characterization, Cytotoxicity, Safety Profile, Antioxidant, and Antimicrobial Potential Against Nosocomial Pathogens.使用葛根素合成AgO/Ag纳米颗粒:表征、细胞毒性、安全性、抗氧化以及对医院病原体的抗菌潜力
J Funct Biomater. 2025 Jul 11;16(7):258. doi: 10.3390/jfb16070258.

本文引用的文献

1
Dual role of Nrf2 signaling in hepatocellular carcinoma: promoting development, immune evasion, and therapeutic challenges.Nrf2 信号通路在肝细胞癌中的双重作用:促进发展、免疫逃逸和治疗挑战。
Front Immunol. 2024 Sep 2;15:1429836. doi: 10.3389/fimmu.2024.1429836. eCollection 2024.
2
Targeting CD73 with flavonoids inhibits cancer stem cells and increases lymphocyte infiltration in a triple-negative breast cancer mouse model.黄酮类化合物靶向 CD73 抑制三阴性乳腺癌小鼠模型中的癌症干细胞并增加淋巴细胞浸润。
Front Immunol. 2024 Mar 27;15:1366197. doi: 10.3389/fimmu.2024.1366197. eCollection 2024.
3
Research progress on the antitumor effects of harmine.
骆驼蓬碱抗肿瘤作用的研究进展
Front Oncol. 2024 Mar 25;14:1382142. doi: 10.3389/fonc.2024.1382142. eCollection 2024.
4
Research Progress of Natural Matrine Compounds and Synthetic Matrine Derivatives.天然苦参碱类化合物及合成苦参碱衍生物的研究进展
Molecules. 2023 Jul 31;28(15):5780. doi: 10.3390/molecules28155780.
5
Mechanistic Insights into Harmine-Mediated Inhibition of Human DNA Methyltransferases and Prostate Cancer Cell Growth.关于 harmine 介导的人源 DNA 甲基转移酶抑制作用及其对前列腺癌细胞生长影响的机制研究
ACS Chem Biol. 2023 Jun 16;18(6):1335-1350. doi: 10.1021/acschembio.3c00065. Epub 2023 May 15.
6
Biosynthesis of anticancer phytochemical compounds and their chemistry.抗癌植物化学化合物的生物合成及其化学性质。
Front Pharmacol. 2023 Mar 9;14:1136779. doi: 10.3389/fphar.2023.1136779. eCollection 2023.
7
Melatonin and 5-fluorouracil combination chemotherapy: opportunities and efficacy in cancer therapy.褪黑素与 5-氟尿嘧啶联合化疗:癌症治疗中的机会和疗效。
Cell Commun Signal. 2023 Feb 9;21(1):33. doi: 10.1186/s12964-023-01047-x.
8
Combination of DNA Damage, Autophagy, and ERK Inhibition: Novel Evodiamine-Inspired Multi-Action Pt(IV) Prodrugs with High-Efficiency and Low-Toxicity Antitumor Activity.DNA 损伤、自噬和 ERK 抑制的联合作用:新型基于吴茱萸碱的多作用 Pt(IV)前药,具有高效低毒的抗肿瘤活性。
J Med Chem. 2023 Feb 9;66(3):1852-1872. doi: 10.1021/acs.jmedchem.2c01660. Epub 2023 Jan 30.
9
Novel strategies to reverse chemoresistance in colorectal cancer.新型策略逆转结直肠癌的化疗耐药性。
Cancer Med. 2023 May;12(10):11073-11096. doi: 10.1002/cam4.5594. Epub 2023 Jan 16.
10
The anti-estrogen receptor drug, tamoxifen, is selectively Lethal to P-glycoprotein-expressing Multidrug resistant tumor cells.抗雌激素受体药物他莫昔芬对表达 P-糖蛋白的多药耐药肿瘤细胞具有选择性杀伤作用。
BMC Cancer. 2023 Jan 6;23(1):24. doi: 10.1186/s12885-022-10474-x.